15-day Paxlovid regimen safe but adds no clear long-COVID benefit

  Science Technology   Jun 12, 2024   0   11  Add to Reading List
15-day Paxlovid regimen safe but adds no clear long-COVID benefit
Preliminary results from a Scripps Research and eMed digital medicine study show an unexpectedly high proportion of COVID-19 rebound cases in untreated people, as well as those treated with Paxlovid.
Preliminary results from a Scripps Research and eMed digital medicine study show an unexpectedly high proportion of COVID-19 rebound cases in untreated people, as well as those treated with Paxlovid.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow